V004-6563 Screening compound: N-cyclohexyl-2-(4-fluorophenyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)acetamide

V004-6563 Screening compound: N-cyclohexyl-2-(4-fluorophenyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)acetamide
V004-6563 Screening compound: N-cyclohexyl-2-(4-fluorophenyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V004-6563
N-cyclohexyl-2-(4-fluorophenyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V004-6563

Molecular Formula

C25H25F4N3O2 (C25 H25 F4 N3 O2)

Compound Name

N-cyclohexyl-2-(4-fluorophenyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)acetamide

IUPAC name

N-cyclohexyl-2-(4-fluorophenyl)-N-(2-{3-[4-(trifluoromethyl)phenyl]-124-oxadiazol-5-yl}ethyl)acetamide

SMILES

O=C(Cc(cc1)ccc1F)N(CCc1nc(-c2ccc(C(F)(F)F)cc2)no1)C1CCCCC1

InChI

InChI=1S/C25H25F4N3O2/c26-20-12-6-17(7-13-20)16-23(33)32(21-4-2-1-3-5-21)15-14-22-30-24(31-34-22)18-8-10-19(11-9-18)25(27,28)29/h6-13,21H,1-5,14-16H2

InChI Key

CMVDSNFLHIVSGT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20489800

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.49

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.630

Distribution Coefficient, logD

6.630

Water Solubility, LogSw

-6.06

Polar Surface Area

46.217

Acid Dissociation Constant (pKa)

18.06

Base Dissociation Constant (pKb)

4.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

V004-6563 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V004-6563 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V004-6563?
Check Price and Availability of V004-6563, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V004-6563 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V004-6563
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V004-6563
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V004-6563 available by request